Clinical Effectiveness of Episodic Use of Bioactive Silica Based Versus in Management of Dentin Hypersensitivity (A 6m Randomized Clinical Trial)
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study to compare the clinical effectiveness of Episodic use of Bioactive Silica Based versus continuous use of fluoride based desensitizing toothpastes in management of dentin hypersensitivity (DH) of adult patients over 6m follow up and evaluating patient satisfaction regarding the treatment provided. Episodic use will be tested as it reflects the effectiveness in a clinical scenario regarding patient compliance and adherence to the treatment where some of the Egyptian patients stop the treatment once improvement occurs due to financial constraints
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedStudy Start
First participant enrolled
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedAugust 13, 2025
August 1, 2025
6 months
August 6, 2025
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of Dentin hypersensitivity
Visual analog scale (VAS)
change from the baseline, 1month, 2months, 4 months, 6 months after treatment
Secondary Outcomes (2)
Examiner Assessment to level of patient pain
change from the baseline, 1month, 2months, 4 months, 6 months after treatment
Patient satisfaction with the Treatment
change from the baseline, 1month, 2months, 4 months, 6 months after treatment
Study Arms (4)
Group 1 Episodic use of Refix booster Bioactive Silica with calcium booster toothpaste
EXPERIMENTALGroup 2: Episodic use of Regenerador Sentitive: Bioactive Silica Based toothpaste,
EXPERIMENTALGroup 3: Episodic use of (Sensodyne Rapid action) Fluoride containing desensitizing Toothpaste,
EXPERIMENTALGroup 4: Continuous use of (Sensodyne Rapid action) Fluoride containing desensitizing Toothpaste
ACTIVE COMPARATORInterventions
subjects assigned to episodic treatment will use the assigned toothpaste with the same previous instructions for two 8-week treatment periods, followed by an 8-week phase in which they will use the conventional fluoride dentifrice (Signal Complete 8 Original, Unilever, Egypt), which has no documented desensitizing efficacy
The patients will be instructed to use 1 inch amount of the assigned desensitizing toothpaste and soft bristle toothbrushes with the same brushing technique they will be taught in the intervention visit for 2 minutes twice a day (morning and last thing at night ) without further rinsing, only spitting of the excess material every day along the whole study period for the continuous treatment group.
Eligibility Criteria
You may qualify if:
- Patients with DH, VAS ≥ 3 and Schiff sensitivity score needed to be ≥2, indicating that application of a jet of air makes the patient respond and move or requests discontinuation of the stimuli application.
- Teeth with DH related to Non- carious Cervical lesions (abrasion, abfracture, erosion).
- Teeth with gingival recession and exposed root dentin.
You may not qualify if:
- Patients with known allergies or adverse reactions to any ingredient of the tested materials.
- Systematic disease and/ or physical disabilities that may affect participation. • Patients who did any periodontal surgeries within the previous 3 months.
- Patients with orthodontic appliances, or restorative work that might interfere with evaluation.
- Patient who frequently use analgesics or any drugs that could affect the pain level.
- Home or in-office bleaching and/ or in office fluoride application for 6 months before beginning of treatment.
- Pregnant females with frequent vomiting attacks.
- Smokers.
- Systemic conditions that cause or predispose patients to develop dentin hypersensitivity (for example, gastroesophageal reflux disease, GERD).
- Excessive dietary or environmental exposure to acids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cairo University
Cairo, 11331, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Conservative dentistry department
Study Record Dates
First Submitted
August 6, 2025
First Posted
August 13, 2025
Study Start
August 20, 2025
Primary Completion
February 20, 2026
Study Completion
February 28, 2026
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share